Page 24 - BH-3-1

Brain & Heart TAVR in low gradient aortic stenosis

64. Cavender MA, Kim SM. Utility of dual antiplatelet therapy quality of life outcomes after tavr in patients with low
for the prevention of subclinical leaflet thrombosis: Now is gradient aortic stenosis. Curr Probl Cardiol. 2024;49:101941.
not the time to halt the use of dual antiplatelet therapy. JACC doi: 10.1016/j.cpcardiol.2023.101941
Cardiovasc Interv. 2019;12:19-21.
75. Freitas-Ferraz AB, Lerakis S, Barbosa Ribeiro H, et al. Mitral
doi: 10.1016/j.jcin.2018.09.040 regurgitation in low-flow, low-gradient aortic stenosis
65. Greco A, Spagnolo M, Capodanno D. Antithrombotic patients undergoing TAVR: Insights from the TOPAS-TAVI
therapy after transcatheter aortic valve implantation. Expert registry. JACC Cardiovasc Interv. 2020;13:567-579.
Rev Med Devices. 2022;19:499-513.
doi: 10.1016/j.jcin.2019.11.042
doi: 10.1080/17434440.2022.2106853
76. Lauten A, Figulla HR, Mollmann H, et al. TAVI for low-
66. Hindi MN, Akodad M, Nestelberger T, Sathananthan J. flow, low-gradient severe aortic stenosis with preserved or
Antithrombotic therapy after transcatheter aortic valve reduced ejection fraction: A subgroup analysis from the
replacement: An overview. Struct Heart. 2022;6:100085. German Aortic Valve Registry (GARY). EuroIntervention.
2014;10:850-859.
doi: 10.1016/j.shj.2022.100085
doi: 10.4244/EIJV10I7A145
67. Ng ACT, Holmes DR, Mack MJ, et al. Leaflet immobility and
thrombosis in transcatheter aortic valve replacement. Eur 77. Kataoka A, Watanabe Y, Kozuma K, et al. Prognostic impact
Heart J. 2020;41:3184-3197. of low-flow severe aortic stenosis in small-body patients
undergoing TAVR: The OCEAN-TAVI registry. JACC
doi: 10.1093/eurheartj/ehaa542
Cardiovasc Imaging. 2018;11:659-669.
68. Yanagisawa R, Tanaka M, Yashima F, et al. Early and
late leaflet thrombosis after transcatheter aortic valve doi: 10.1016/j.jcmg.2016.12.028
replacement. Circ Cardiovasc Interv. 2019;12:e007349. 78. Fischer-Rasokat U, Renker M, Liebetrau C, et al. 1-year
survival after TAVR of patients with low-flow, low-gradient
doi: 10.1161/CIRCINTERVENTIONS.118.007349
and high-gradient aortic valve stenosis in matched study
69. Vollema EM, Kong WKF, Katsanos S, et al. Transcatheter aortic populations. JACC Cardiovasc Interv. 2019;12:752-763.
valve thrombosis: The relation between hypo-attenuated doi: 10.1016/j.jcin.2019.01.233.
leaflet thickening, abnormal valve haemodynamics, and
stroke. Eur Heart J. 2017;38:1207-1217. 79. Saito Y, Lewis EE, Raval A, Gimelli G, Jacobson K, Osaki S.
Prognosis of paradoxical low-flow low-gradient aortic
doi: 10.1093/eurheartj/ehx031
stenosis after transcatheter aortic valve replacement.
70. Herrmann HC, Pibarot P, Hueter I, et al. Predictors of J Cardiovasc Med (Hagerstown). 2021;22:486-491.
mortality and outcomes of therapy in low-flow severe doi: 10.2459/JCM.0000000000001139
aortic stenosis: A placement of aortic transcatheter valves
(PARTNER) trial analysis. Circulation. 2013;127:2316-2326. 80. Osman M, Ghaffar YA, Foster T, et al. Meta-analysis of
outcomes of transcatheter aortic valve implantation among
doi: 10.1161/CIRCULATIONAHA.112.001290
patients with low gradient severe aortic stenosis. Am J
71. Ribeiro HB, Lerakis S, Gilard M, et al. Transcatheter aortic Cardiol. 2019;124:423-429.
valve replacement in patients with low-flow, low-gradient doi: 10.1016/j.amjcard.2019.05.006.
aortic stenosis: The TOPAS-TAVI registry. J Am Coll Cardiol.
2018;71:1297-1308. 81. Takagi H, Hari Y, Kawai N, Kuno T, Ando T, Group A. A meta-
analysis of impact of low-flow/low-gradient aortic stenosis
doi: 10.1016/j.jacc.2018.01.054
on survival after transcatheter aortic valve implantation.
72. Maes F, Lerakis S, Barbosa Ribeiro H, et al. Outcomes from J Cardiovasc Med (Hagerstown). 2019;20:691-698.
transcatheter aortic valve replacement in patients with low- doi: 10.2459/JCM.0000000000000836
flow, low-gradient aortic stenosis and left ventricular ejection
fraction less than 30%: A substudy from the TOPAS-TAVI 82. Rodriguez-Gabella T, Nombela-Franco L, Auffret V, et al.
registry. JAMA Cardiol. 2019;4:64-70. Transcatheter aortic valve implantation in patients with
paradoxical low-flow, low-gradient aortic stenosis. Am J
doi: 10.1001/jamacardio.2018.4320
Cardiol. 2018;122:625-632.
73. Dayan V, Vignolo G, Magne J, Clavel MA, Mohty D, doi: 10.1016/j.amjcard.2018.04.044
Pibarot P. Outcome and impact of aortic valve replacement
in patients with preserved LVEF and low-gradient aortic 83. Ozkan A, Hachamovitch R, Kapadia SR, Tuzcu EM,
stenosis. J Am Coll Cardiol. 2015;66:2594-2603. Marwick TH. Impact of aortic valve replacement on
outcome of symptomatic patients with severe aortic stenosis
doi: 10.1016/j.jacc.2015.09.076
with low gradient and preserved left ventricular ejection
74. Chiang C, Brandon M, Danley K, et al. Functional and fraction. Circulation. 2013;128:622-631.

Volume 3 Issue 1 (2025) 18 doi: 10.36922/bh.4017